Цена акции Dyadic International (DYAI) сегодня, премаркет и постмаркет

Данные

Суперграфики

Legend

Ещё

Поиск

Dyadic International, Inc.

DYAI

Nasdaq

Health Services

Medical/Nursing Services

1.19

USD

-0.02

-1.65%

Закрыт: 07-24 20:00 (UTC+0)

1.19

USD

+0.0559

+4.70%

После закрытия: 07-25 00:00 (UTC+0)

DYAI Ключевая статистика

Максимум

1.26

Открыть

1.21

Объем

105.18K

Минимум

1.12

Предыдущее закрытие

1.21

Объем торгов

125.54K

Макс. 52 нед.

1.60

Отн. объем

0.371

Амплитуда (%)

11.49%

Мин. 52 нед.

0.65

Коэф. оборота

0.29%

Рыночная капитализация

43.36M

P/E (TTM)

P/E (год.)

P/B

-106.35

P/S

11.39

Прибыль на акцию (EPS)

-0.214

Дивиденд (TTM)

Дивидендная доходность

0.00%

Акции в обращении

36.43M

Валюта

USD

DYAI Доходность цены

7 день

30 день

90 день

180 день

С начала года

1 Год

DYAI Распределение денежных потоков

DYAI Дневной объем коротких продаж

DYAI История short interest

Обзор акции DYAI

As of 2026-07-26, the Dyadic International, Inc. (DYAI) stock price today is 1.19. Based on this price, the company has a market capitalization of $43.36M, with a P/E ratio of --. On 2026-07-26, DYAI traded between 1.12 and 1.26. Today’s stock price is 6.25% above the daily low and 5.56% below the daily high, placing DYAI примерно в середине its most recent trading range. Trading volume currently stands at 105.18K, compared with an average daily volume of 283.91K. This suggests that trading activity is значительно ниже обычного уровня than usual. Over the past year, Dyadic International, Inc. shares have traded between 0.65 and 1.60. At today’s price, DYAI is 83.08% above its 52-week low and 25.63% below its 52-week high.

DYAI Связанные новости

О нас DYAI

Название компании

Dyadic International, Inc.

Сектор

Health Services

Отрасль

Medical/Nursing Services

Биржи

Nasdaq

Количество сотрудников

Размер лота

100

Официальный сайт

www.dyadic.com

Валюта

USD

Dyadic International Inc is a biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.

Related Stocks

DYAI FAQ

1.What is the live stock price of Dyadic International, Inc. (DYAI) today?

3. What is the latest pre-market price of DYAI?

5.How has DYAI’s stock price performed recently?

7. What is the current capital flow for DYAI?

9. What is the current price of NVDA stock perps?

11. What is the market capitalization of Dyadic International, Inc.?

13. What is Dyadic International, Inc.’s earnings per share (EPS)?

15. Does Dyadic International, Inc. pay dividends?

17. How many employees does Dyadic International, Inc. have?

2. What were DYAI’s trading range and trading volume on the most recent trading day?

4.What is DYAI’s after-hours price?

6. What are DYAI’s 52-week high and 52-week low?

8. What are DYAI’s short sale volume and short interest?

10. What are Dyadic International, Inc.’s P/E ratio and valuation metrics?

12. What were Dyadic International, Inc.’s revenue and net income in the most recent quarter?

14.What is Dyadic International, Inc.’s total number of shares outstanding?

16. Which exchange is Dyadic International, Inc. listed on, and what sector and industry does it belong to?

18. What risks should investors consider before investing in DYAI?